Study: J&J Vaccine 66% Effective Against COVID-19

Name: Study: J&J Vaccine 66% Effective Against COVID-19
Uploaded: 2021-04-22T22:00:06+00:00
Duration: 24 s
Description: Right now the Johnson and Johnson COVID-19 vaccine is on pause in the U.S. because of concerns over a possible link to rare cases of blood clots.

Newsy Published April 22, 2021 770 Views

Rumble — Right now the Johnson and Johnson COVID-19 vaccine is on pause in the U.S. because of concerns over a possible link to rare cases of blood clots.